about
Anti-EGFR antibody efficiently and specifically inhibits human TSC2-/- smooth muscle cell proliferation. Possible treatment options for TSC and LAM.Lymphangioleiomyomatosis and TSC2-/- cellsGlycosaminoglycans co-administration enhance insulin-like growth factor-I neuroprotective and neuroregenerative activity in traumatic and genetic models of motor neuron disease: a review.TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival.Anti-EGFR antibody reduces lung nodules by inhibition of EGFR-pathway in a model of lymphangioleiomyomatosis.Che-1-induced inhibition of mTOR pathway enables stress-induced autophagy.Role of Prolactin Receptors in Lymphangioleiomyomatosis.Women with TSC: Relationship between Clinical, Lung Function and Radiological Features in a Genotyped Population Investigated for Lymphangioleiomyomatosis.The methylation of the TSC2 promoter underlies the abnormal growth of TSC2 angiomyolipoma-derived smooth muscle cellsTargeting Notch as a Therapeutic Approach for Human Malignancies.Chromatin remodeling by rosuvastatin normalizes TSC2-/meth cell phenotype through the expression of tuberin.Loss of the inactive X chromosome and replication of the active X in BRCA1-defective and wild-type breast cancer cells.Lymphangioleiomyomatosis, multifocal micronodular pneumocyte hyperplasia, and sarcoidosis: more pathological findings in the same chest CT, or a single pathological pathway?Diabetic neuropathy in the rat: 1. Alcar augments the reduced levels and axoplasmic transport of substance P.Acute spinal cord injury persistently reduces R/G RNA editing of AMPA receptors.High opioid doses inhibit whereas low doses enhance neuritogenesis in PC12 cells.Development of a lymphangioleiomyomatosis model by endonasal administration of human TSC2-/- smooth muscle cells in mice.G protein-mediated signal transduction is affected in primary biliary cirrhosis.Glioblastoma multiforme in a child with tuberous sclerosis complex.Co-administration of IGF-I and glycosaminoglycans greatly delays motor neurone disease and affects IGF-I expression in the wobbler mouse: a long-term studyGlycosaminoglycans boost insulin-like growth factor-I-promoted neuroprotection: blockade of motor neuron death in the wobbler mouseLong-term neuroprotective effects of glycosaminoglycans-IGF-I cotreatment in the motor neuron degeneration (mnd ) mutant mouseGlycosaminoglycan Supplementation Promotes Nerve Regeneration and Muscle ReinnervationPerinatal exposure to morphine: reactive changes in the brain after 6-hydroxydopaminePerinatal morphine II: Changes in cortical plasticityGlycosaminoglycans treatment increases IGF-I muscle levels and counteracts motor neuron death: A novel nonanticoagulant actionAdipose-Derived Stem Cells from Fat Tissue of Breast Cancer Microenvironment Present Altered Adipogenic Differentiation CapabilitiesExtracellular Vesicles Enhance Multiple Myeloma Metastatic Dissemination
P50
Q33380187-E5658E87-A929-49EC-B1A5-AAFF50D57C33Q33904951-6ED42F3C-FE6B-4A1D-900B-5CAE34B7C5C8Q33922338-7CC30384-A379-4E0A-AABF-9DC37ABC4A0FQ33991599-C61299E4-6CC5-4986-9CD0-34D5E6CEA9EBQ35074335-A94C8FC5-29B0-42C1-BAF4-DB0F3A0CCA40Q35590396-A475546F-27E6-443B-A8FF-EA7DD811A889Q35893800-CCE44AAB-2C5E-4747-AB74-FC3CA7D08CDAQ36015287-6AF31CC8-6A13-405D-A475-D5B44B5CC370Q37197352-C2C32177-615C-4D1F-A528-B8EFD2066743Q38975790-FC8F7011-3C66-4C27-8AE4-64D2CD6E23A6Q39191279-C1466C5F-84D8-4EFD-B5BD-21781A44ACF6Q40444169-C1485A51-D8B3-42BF-AA33-2EB756BAAD3AQ42339313-AF56ABFA-C738-46E4-9324-BB82DEF11C05Q42477480-B9161D46-6CE7-44BE-9AE4-7DC25B7C83C3Q43067888-592ADDE0-B9D2-4409-92D4-E73BBF53694FQ44343214-FE7B6B81-C79D-4F56-8D97-848A9A064E1AQ51327159-AD288413-2D80-4CBF-86C7-A76E4CE5A11BQ51813330-2173F393-DBEE-4170-BBA1-EA310802CD42Q53517722-D43D9ED8-1EC5-4A25-8A4A-75EC28C2D5CBQ60649901-9FE2CEF1-6A32-40F7-8996-2FCDBE09AC2EQ60649902-81FF57E8-025D-4104-A0A9-7070340DD115Q60649903-862D6EC2-ABF5-4A8C-B417-D93A52B8CB78Q60649904-0E2E97D8-415C-41D6-9556-FB47852EEF88Q60649906-1883D2B4-A376-4094-A49A-19A74767200FQ60649908-5F085518-3DD5-4081-9529-922B6D9248DDQ73561752-64CE19F3-FA5B-4DA9-9509-54B82C4FFEA8Q90069833-31FDC202-DD6D-4871-BAC8-E333746B989BQ91558497-88C417BB-E4B4-4D2E-9015-9741432A3392
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Elena Lesma
@ast
Elena Lesma
@en
Elena Lesma
@es
Elena Lesma
@nl
Elena Lesma
@sl
type
label
Elena Lesma
@ast
Elena Lesma
@en
Elena Lesma
@es
Elena Lesma
@nl
Elena Lesma
@sl
prefLabel
Elena Lesma
@ast
Elena Lesma
@en
Elena Lesma
@es
Elena Lesma
@nl
Elena Lesma
@sl
P106
P1153
6602222730
P21
P31
P496
0000-0002-9096-713X